Genpact (G)
Market Price (12/18/2025): $47.93 | Market Cap: $8.3 BilSector: Industrials | Industry: Data Processing & Outsourced Services
Genpact (G)
Market Price (12/18/2025): $47.93Market Cap: $8.3 BilSector: IndustrialsIndustry: Data Processing & Outsourced Services
Investment Highlights
Why It Matters
Which of these 2 stories sounds closer for this stock?
1. Generates cash flow
The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.
2. Riding a trend
Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 9.2%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 5.0%, FCF Yield is 8.8% | Weak multi-year price returns2Y Excs Rtn is -0.4%, 3Y Excs Rtn is -57% | Key risksG key risks include [1] a failure to adapt to disruptive AI and retain skilled talent and [2] financial vulnerability to foreign currency fluctuations, Show more. |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 15%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 13% | ||
| Low stock price volatilityVol 12M is 33% | ||
| Megatrend and thematic driversMegatrends include Automation & Robotics, Autonomous Technologies, and Digital Health & Telemedicine. Themes include Process / Warehouse Automation, Show more. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 9.2%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 5.0%, FCF Yield is 8.8% |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 15%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 13% |
| Low stock price volatilityVol 12M is 33% |
| Megatrend and thematic driversMegatrends include Automation & Robotics, Autonomous Technologies, and Digital Health & Telemedicine. Themes include Process / Warehouse Automation, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -0.4%, 3Y Excs Rtn is -57% |
| Key risksG key risks include [1] a failure to adapt to disruptive AI and retain skilled talent and [2] financial vulnerability to foreign currency fluctuations, Show more. |
Valuation, Metrics & Events
G Stock
Why The Stock Moved
Qualitative Assessment
AI Generated Analysis | Feedback
Here are the key points for why Genpact's stock moved during the approximate time period from August 31, 2025, to December 18, 2025: 1. Genpact reported strong second-quarter 2025 financial results on August 7, 2025, which included net revenues increasing by 6.6% year-over-year to $1.254 billion. The company also significantly raised its full-year 2025 revenue guidance to a range of 4.0% to 6.0%, or 3.7% to 5.7% on a constant currency basis. 2. The company announced a global rebrand on September 8, 2025, signaling a strategic pivot to become an "agentic and advanced technology solutions company." This rebrand, which included ringing the opening bell at the New York Stock Exchange, highlighted Genpact's updated growth model, GenpactNext, focusing on artificial intelligence (AI) and process intelligence to drive client transformation. 3.
Show moreStock Movement Drivers
Return vs. Risk
Price Returns Compared
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| G Return | -1% | 30% | -12% | -24% | 26% | 13% | 22% |
| Peers Return | � | � | -29% | 2% | 5% | -11% | � |
| S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 14% | 108% |
Monthly Win Rates [3] | |||||||
| G Win Rate | 67% | 58% | 42% | 50% | 50% | 58% | |
| Peers Win Rate | � | 67% | 40% | 53% | 55% | 48% | |
| S&P 500 Win Rate | 58% | 75% | 42% | 67% | 75% | 73% | |
Max Drawdowns [4] | |||||||
| G Max Drawdown | -46% | -7% | -27% | -31% | -12% | -11% | |
| Peers Max Drawdown | � | � | -43% | -26% | -24% | -24% | |
| S&P 500 Max Drawdown | -31% | -1% | -25% | -1% | -2% | -15% | |
[1] Cumulative total returns since the beginning of 2020
[2] Peers: ACN, CTSH, EXLS, CNXC, TASK. See G Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/17/2025 (YTD)
How Low Can It Go
| Event | G | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -41.1% | -25.4% |
| % Gain to Breakeven | 69.8% | 34.1% |
| Time to Breakeven | 456 days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -49.6% | -33.9% |
| % Gain to Breakeven | 98.4% | 51.3% |
| Time to Breakeven | 401 days | 148 days |
| 2018 Correction | ||
| % Loss | -25.5% | -19.8% |
| % Gain to Breakeven | 34.3% | 24.7% |
| Time to Breakeven | 94 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -64.1% | -56.8% |
| % Gain to Breakeven | 178.9% | 131.3% |
| Time to Breakeven | 527 days | 1,480 days |
Compare to IBM, ACN, EXLS, XRX, BR
In The Past
Genpact's stock fell -41.1% during the 2022 Inflation Shock from a high on 12/29/2021. A -41.1% loss requires a 69.8% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth over time.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
Latest Trefis Analyses
| Title | Topic | Date | |
|---|---|---|---|
| DASHBOARDS | |||
| Is Genpact Stock Built to Withstand a Pullback? | Return | ||
| G Dip Buy Analysis | |||
| Genpact Total Shareholder Return (TSR): 27.2% in 2024 and -4.1% 3-yr compounded annual returns (below peer average) | |||
| Genpact (G) Operating Cash Flow Comparison | Financials | ||
| Genpact (G) Net Income Comparison | Financials | ||
| Genpact (G) Operating Income Comparison | Financials | ||
| Genpact (G) Revenue Comparison | Financials | ||
| Genpact vs. Schlumberger: G stock's substantially higher valuation vs. SLB appears counterintuitive | Counter-Intuitive Comparisons | ||
| Genpact vs. Pilgrims Pride: G stock's significantly higher valuation vs. PPC appears counterintuitive | Counter-Intuitive Comparisons | ||
| Genpact vs. PG&E: G stock's substantially higher valuation vs. PCG appears counterintuitive | Counter-Intuitive Comparisons | ||
| ARTICLES | |||
| Is Wall Street Undervaluing G Stock? | September 5th, 2025 |
Trade Ideas
Select past ideas related to G. For more, see Trefis Trade Ideas.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 11212025 | CNM | Core & Main | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 19.8% | 19.8% | -1.6% |
| 11212025 | VRRM | Verra Mobility | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 2.2% | 2.2% | -1.2% |
| 11212025 | LII | Lennox International | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 5.9% | 5.9% | 0.0% |
| 11212025 | ADP | Automatic Data Processing | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | 4.2% | 4.2% | -1.2% |
| 11212025 | CW | Curtiss-Wright | Quality | Q | Momentum | UpsideQuality Stocks with Momentum and UpsideBuying quality stocks with strong momentum but still having room to run | 1.5% | 1.5% | 0.0% |
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 11212025 | CNM | Core & Main | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 19.8% | 19.8% | -1.6% |
| 11212025 | VRRM | Verra Mobility | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 2.2% | 2.2% | -1.2% |
| 11212025 | LII | Lennox International | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 5.9% | 5.9% | 0.0% |
| 11212025 | ADP | Automatic Data Processing | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | 4.2% | 4.2% | -1.2% |
| 11212025 | CW | Curtiss-Wright | Quality | Q | Momentum | UpsideQuality Stocks with Momentum and UpsideBuying quality stocks with strong momentum but still having room to run | 1.5% | 1.5% | 0.0% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons for Genpact
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 45.19 |
| Mkt Cap | 7.6 |
| Rev LTM | 7,365 |
| Op Inc LTM | 681 |
| FCF LTM | 579 |
| FCF 3Y Avg | 508 |
| CFO LTM | 738 |
| CFO 3Y Avg | 651 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 7.4% |
| Rev Chg 3Y Avg | 6.0% |
| Rev Chg Q | 7.3% |
| QoQ Delta Rev Chg LTM | 1.8% |
| Op Mgn LTM | 14.9% |
| Op Mgn 3Y Avg | 14.4% |
| QoQ Delta Op Mgn LTM | 0.0% |
| CFO/Rev LTM | 14.3% |
| CFO/Rev 3Y Avg | 13.6% |
| FCF/Rev LTM | 12.8% |
| FCF/Rev 3Y Avg | 10.9% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 7.6 |
| P/S | 1.5 |
| P/EBIT | 9.6 |
| P/E | 17.5 |
| P/CFO | 11.0 |
| Total Yield | 7.2% |
| Dividend Yield | 1.0% |
| FCF Yield 3Y Avg | 6.1% |
| D/E | 0.1 |
| Net D/E | 0.0 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 11.7% |
| 3M Rtn | 6.9% |
| 6M Rtn | -7.9% |
| 12M Rtn | -4.8% |
| 3Y Rtn | 10.3% |
| 1M Excs Rtn | 11.0% |
| 3M Excs Rtn | 6.2% |
| 6M Excs Rtn | -20.3% |
| 12M Excs Rtn | -18.4% |
| 3Y Excs Rtn | -63.6% |
Comparison Analyses
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 11/6/2025 | 15.9% | 17.3% | 19.6% |
| 8/7/2025 | 4.4% | 4.7% | 6.1% |
| 5/7/2025 | -15.2% | -12.8% | -13.0% |
| 2/6/2025 | 11.2% | 12.4% | 1.7% |
| 11/7/2024 | 9.9% | 7.9% | 7.6% |
| 8/8/2024 | 15.7% | 18.0% | 19.6% |
| 5/9/2024 | 3.6% | 7.4% | 3.1% |
| 2/8/2024 | 4.6% | 2.8% | -2.5% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 13 | 15 | 12 |
| # Negative | 11 | 9 | 12 |
| Median Positive | 4.6% | 4.7% | 5.4% |
| Median Negative | -3.3% | -3.5% | -3.9% |
| Max Positive | 15.9% | 18.0% | 19.6% |
| Max Negative | -15.2% | -12.8% | -19.7% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 9302025 | 11072025 | 10-Q 9/30/2025 |
| 6302025 | 8112025 | 10-Q 6/30/2025 |
| 3312025 | 5122025 | 10-Q 3/31/2025 |
| 12312024 | 3032025 | 10-K 12/31/2024 |
| 9302024 | 11122024 | 10-Q 9/30/2024 |
| 6302024 | 8092024 | 10-Q 6/30/2024 |
| 3312024 | 5102024 | 10-Q 3/31/2024 |
| 12312023 | 2292024 | 10-K 12/31/2023 |
| 9302023 | 11092023 | 10-Q 9/30/2023 |
| 6302023 | 8092023 | 10-Q 6/30/2023 |
| 3312023 | 5102023 | 10-Q 3/31/2023 |
| 12312022 | 3012023 | 10-K 12/31/2022 |
| 9302022 | 11092022 | 10-Q 9/30/2022 |
| 6302022 | 8092022 | 10-Q 6/30/2022 |
| 3312022 | 5102022 | 10-Q 3/31/2022 |
| 12312021 | 3012022 | 10-K 12/31/2021 |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |